SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-075599
Filing Date
2019-03-15
Accepted
2019-03-15 07:03:03
Documents
5
Period of Report
2019-03-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d709280d8k.htm 8-K 32506
2 EX-10.1 d709280dex101.htm EX-10.1 129981
3 EX-10.2 d709280dex102.htm EX-10.2 36690
4 EX-99.1 d709280dex991.htm EX-99.1 14150
5 GRAPHIC g709280g0314114233003.jpg GRAPHIC 3404
  Complete submission text file 0001193125-19-075599.txt   219311
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Filer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35993 | Film No.: 19682889
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1